Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial

INTRODUCTION: Coagulopathic bleeding is a serious complication of cardiac surgery to which an important contributor is acquired hypofibrinogenaemia (plasma fibrinogen <1.5–2.0 g/L). The standard intervention for acquired hypofibrinogenaemia is cryoprecipitate, but purified fibrinogen concentrates...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Open
Hlavní autoři: Karkouti, Keyvan, Callum, Jeannie, Rao, Vivek, Heddle, Nancy, Farkouh, Michael E, Crowther, Mark A, Scales, Damon C
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2018
Témata:
Haematology (Incl Blood Transfusion)
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5914770/
https://ncbi.nlm.nih.gov/pubmed/29678987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-020741
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky